A pd-mediated new strategy to functionalized 2-aminochromenes: Their in vitro evaluation as potential anti tuberculosis agents

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 21, 2011, Pages 6433-6439

  Reddy, T Ram ^a,b   Reddy, L Srinivasula ^a,b   Reddy, Rajeshwar ^a   Nuthalapati, Venkata Subbaiah ^a   Lingappa, Y ^b   Sandra, Sandhya ^c   Kapavarapu, Ravikumar ^c   Misra, Parimal ^c   Pal, Manojit ^c  

^a DR REDDY'S LABORATORIES LTD   (India)

^b SRI VENKATESWARA UNIVERSITY   (India)

^c INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

2 Aminochromenes; Chorismate mutase; Multi component reactions (MCRs); Palladium

Indexed keywords

2 AMINOCHROMENE; CHORISMATE MUTASE; PALLADIUM; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL REACTION; IN VITRO STUDY; MULTICOMPONENT REACTION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

MYCOBACTERIUM TUBERCULOSIS;

EID: 80054781347     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.08.088     Document Type: Article

References (20)

1. Haslam, E. Shikimic Acid: Metabolism and Metabolites; Wiley: New York, 1993.
2. For selected references, see: (a) Agarwal, H.; Kumar, A.; Bal, N. C.; Siddiqi, M. I.; Arora, A. Bioorg. Med. Chem. Lett. 2007, 17, 3053;
3. (b) Hediger, M. E. Bioorg. Med. Chem. 2004, 12, 4995;
4. (c) Bartlett, P. A.; Nakagawa, Y.; Johnson, C. R.; Reich, S. H.; Luis, A. J. Org. Chem. 1988, 53, 3195.
5. Armstrong, R. W.; Combs, A. P.; Tempest, P. A.; Brown, S. D.; Keating, T. A. Acc. Chem. Res. 1996, 29, 123.
6. For recent progress in the chemistry of multicomponent reactions, see: Ugi, I. Pure Appl. Chem. 2001, 73, 187.
7. Dömling, A. Curr. Opin. Chem. Biol. 2000, 4, 318.
8. (a) Merkul, E.; Boersch, C.; Frank, W.; Muller, T. J. J. Org. Lett. 2009, 11, 2269;
9. (b) Banfi, L.; Basso, A.; Cerulli, V.; Guanti, G.; Riva, R. J. Org. Chem. 2008, 73, 1608;
10. (c) Umkehrer, M.; Kalinski, C.; Kolb, J.; Burdack, C. Tetrahedron Lett. 2006, 47, 2391.
11. Kidwai, M.; Saxena, S.; Khan, M. K. R.; Thukral, S. S. Bioorg. Med. Chem. Lett. 2005, 15, 4295.
12. Heravi, M. M.; Bakhtiari, K.; Zadsirjan, V.; Bamoharram, F. F.; Heravi, O. M. Bioorg. Med. Chem. Lett. 2007, 17, 4262.
13. Elinson, M. N.; Ilovaisky, A. I.; Merkulova, V. M.; Belyakov, P. A.; Chizhov, A. O.; Nikishin, G. I. Tetrahedron 2010, 66, 4043.
14. (a) Zhou, D.; Chen, R. Z. J.; Cao, W.; Deng, H. J. Heterocycl. Chem. 2009, 45, 1865;
15. (b) Shestopalov, A. M.; Emelianova, Y. M.; Nesterov, V. N. Russ. Chem. Bull., Int. Ed. 2002, 51, 2238.
16. Elagamay, A. G. A.; El-Taweel, F. M. A. A. Indian J. Chem. B 1990, 29, 885.
17. 2 (0.002 mmol) and pyrrolidine (5 mmol) was added at 0-5 °C. The resulting mixture was stirred at 0-5 °C for 30 min and then at 70 °C for the duration as indicated in Table 2. The desired product 5 was isolated after usual work-up (see the Supplementary data).
18. (a) Kim, S. K.; Reddy, S. K.; Nelson, B. C.; Vasquez, G. B.; Davis, A.; Howard, A. J.; Patterson, S.; Gilliland, G. L.; Ladner, J. E.; Reddy, P. T. J. Bacteriol. 2006, 188, 8638
19. (b) Sasso, S.; Ramakrishnan, C.; Gamper, M.; Hilvert, D.; Kast, P. FEBS J. 2005, 272, 375.
20. Precipitation of the compound 5 observed in most of the cases in assay medium.